Global Market Report

Global U.S. Generic Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 06, 2019
  • PAGES：182
  • REPORT CODE：GMM181576
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of U.S. Generic Drugs witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 U.S. Generic Drugs market is offered. The research provides insights for the global U.S. Generic Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the U.S. Generic Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global U.S. Generic Drugs Market Segmentations:

    By Players:

    • Teva Pharmaceuticals USA

    • Endo International

    • Amneal Pharmaceuticals

    • Sandoz

    • Zydus Pharmaceuticals

    • Mylan

    • Actavis

    • Dr. Reddy's Laboratories

    • Pfizer

    • Lupin


    By Types:

    • Type 1

    • Type 2

    • Type 3


    By End-User:

    • End-Users 1

    • End-Users 2

    • End-Users 3


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the U.S. Generic Drugs Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • U.S. Generic Drugs Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of U.S. Generic Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global U.S. Generic Drugs Market Share by Types

      • 1.3.2 Global U.S. Generic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

      • 1.3.3 Global U.S. Generic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

      • 1.3.4 Global U.S. Generic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global U.S. Generic Drugs Market Share by End-Users

      • 1.4.2 Global U.S. Generic Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

      • 1.4.3 Global U.S. Generic Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

      • 1.4.4 Global U.S. Generic Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumU.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of U.S. Generic Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of U.S. Generic Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Type 1

      • 3.4.2 Market Size and Growth Rate of Type 2

      • 3.4.3 Market Size and Growth Rate of Type 3


    4 Segmentation of U.S. Generic Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of U.S. Generic Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of U.S. Generic Drugs for End-Users 1

      • 4.4.2 Market Size and Growth Rate of U.S. Generic Drugs for End-Users 2

      • 4.4.3 Market Size and Growth Rate of U.S. Generic Drugs for End-Users 3


    5 Market Analysis by Major Regions

    • 5.1 Global U.S. Generic Drugs Production Analysis by Major Regions

    • 5.2 Global U.S. Generic Drugs Consumption Analysis by Major Regions

    • 5.3 Global U.S. Generic Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America U.S. Generic Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe U.S. Generic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific U.S. Generic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa U.S. Generic Drugs Production, Import, Consumption and Export Analysis


    6 Product Commodity of U.S. Generic Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in U.S. Generic Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in U.S. Generic Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in U.S. Generic Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in U.S. Generic Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in U.S. Generic Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in U.S. Generic Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America U.S. Generic Drugs Landscape Analysis

    • 7.1 North America U.S. Generic Drugs Landscape Analysis by Major Types

    • 7.2 North America U.S. Generic Drugs Landscape Analysis by Major End-Users

    • 7.3 North America U.S. Generic Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States U.S. Generic Drugs Market Volume and Growth Rate

      • 7.3.2 Canada U.S. Generic Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico U.S. Generic Drugs Market Volume and Growth Rate


    8 Europe U.S. Generic Drugs Landscape Analysis

    • 8.1 Europe U.S. Generic Drugs Landscape Analysis by Major Types

    • 8.2 Europe U.S. Generic Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe U.S. Generic Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.2 UK U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.3 France U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.4 Italy U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.6 Spain U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.8 Poland U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.9 Russia U.S. Generic Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey U.S. Generic Drugs Market Volume and Growth Rate


    9 Asia Pacific U.S. Generic Drugs Landscape Analysis

    • 9.1 Asia Pacific U.S. Generic Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific U.S. Generic Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific U.S. Generic Drugs Landscape Analysis by Major Countries

      • 9.3.1 China U.S. Generic Drugs Market Volume and Growth Rate

      • 9.3.2 Japan U.S. Generic Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand U.S. Generic Drugs Market Volume and Growth Rate

      • 9.3.4 India U.S. Generic Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries U.S. Generic Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea U.S. Generic Drugs Market Volume and Growth Rate


    10 Latin America, Middle East & Africa U.S. Generic Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa U.S. Generic Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa U.S. Generic Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa U.S. Generic Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries U.S. Generic Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil U.S. Generic Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria U.S. Generic Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa U.S. Generic Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina U.S. Generic Drugs Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Teva Pharmaceuticals USA

      • 11.1.1 Teva Pharmaceuticals USA Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Endo International

      • 11.2.1 Endo International Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Amneal Pharmaceuticals

      • 11.3.1 Amneal Pharmaceuticals Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sandoz

      • 11.4.1 Sandoz Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Zydus Pharmaceuticals

      • 11.5.1 Zydus Pharmaceuticals Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Mylan

      • 11.6.1 Mylan Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Actavis

      • 11.7.1 Actavis Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Dr. Reddy's Laboratories

      • 11.8.1 Dr. Reddy's Laboratories Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Lupin

      • 11.10.1 Lupin Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 100 Figures and 166 Tables)

    • Figure Product Picture

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of Type 1 from 2014 to 2026

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of Type 2 from 2014 to 2026

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of Type 3 from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • Figure Global U.S. Generic Drugs Market Size and Growth Rate of End-User 3 from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina U.S. Generic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of U.S. Generic Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of U.S. Generic Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of U.S. Generic Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of U.S. Generic Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Type 1

    • Figure Market Size and Growth Rate of Type 2

    • Figure Market Size and Growth Rate of Type 3

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of U.S. Generic Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of U.S. Generic Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of End-User 1

    • Figure Market Size and Growth Rate of End-User 2

    • Figure Market Size and Growth Rate of End-User 3

    • Table Global U.S. Generic Drugs Production by Major Regions

    • Table Global U.S. Generic Drugs Production Share by Major Regions

    • Figure Global U.S. Generic Drugs Production Share by Major Regions in 2014

    • Figure Global U.S. Generic Drugs Production Share by Major Regions in 2018

    • Figure Global U.S. Generic Drugs Production Share by Major Regions in 2026

    • Table Global U.S. Generic Drugs Consumption by Major Regions

    • Table Global U.S. Generic Drugs Consumption Share by Major Regions

    • Figure Global U.S. Generic Drugs Consumption Share by Major Regions in 2014

    • Figure Global U.S. Generic Drugs Consumption Share by Major Regions in 2018

    • Figure Global U.S. Generic Drugs Consumption Share by Major Regions in 2026

    • Table North America U.S. Generic Drugs Production, Import, Consumption and Export Analysis

    • Table Europe U.S. Generic Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific U.S. Generic Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in U.S. Generic Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in U.S. Generic Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in U.S. Generic Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in U.S. Generic Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America U.S. Generic Drugs Consumption by Types from 2014 to 2026

    • Table North America U.S. Generic Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America U.S. Generic Drugs Consumption Share by Types in 2014

    • Figure North America U.S. Generic Drugs Consumption Share by Types in 2018

    • Figure North America U.S. Generic Drugs Consumption Share by Types in 2026

    • Table North America U.S. Generic Drugs Consumption by End-Users from 2014 to 2026

    • Table North America U.S. Generic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America U.S. Generic Drugs Consumption Share by End-Users in 2014

    • Figure North America U.S. Generic Drugs Consumption Share by End-Users in 2018

    • Figure North America U.S. Generic Drugs Consumption Share by End-Users in 2026

    • Table North America U.S. Generic Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America U.S. Generic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America U.S. Generic Drugs Consumption Share by Major Countries in 2014

    • Figure North America U.S. Generic Drugs Consumption Share by Major Countries in 2018

    • Figure North America U.S. Generic Drugs Consumption Share by Major Countries in 2026

    • Figure United States U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe U.S. Generic Drugs Consumption by Types from 2014 to 2026

    • Table Europe U.S. Generic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe U.S. Generic Drugs Consumption Share by Types in 2014

    • Figure Europe U.S. Generic Drugs Consumption Share by Types in 2018

    • Figure Europe U.S. Generic Drugs Consumption Share by Types in 2026

    • Table Europe U.S. Generic Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe U.S. Generic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe U.S. Generic Drugs Consumption Share by End-Users in 2014

    • Figure Europe U.S. Generic Drugs Consumption Share by End-Users in 2018

    • Figure Europe U.S. Generic Drugs Consumption Share by End-Users in 2026

    • Table Europe U.S. Generic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe U.S. Generic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe U.S. Generic Drugs Consumption Share by Major Countries in 2014

    • Figure Europe U.S. Generic Drugs Consumption Share by Major Countries in 2018

    • Figure Europe U.S. Generic Drugs Consumption Share by Major Countries in 2026

    • Figure Germany U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Types in 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific U.S. Generic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific U.S. Generic Drugs Consumption Share by Major Countries in 2026

    • Figure China U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandU.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa U.S. Generic Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina U.S. Generic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Teva Pharmaceuticals USA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals USA

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals USA

    • Figure Revenue and Market Share Analysis of Teva Pharmaceuticals USA

    • Table Product and Service Introduction of Teva Pharmaceuticals USA

    • Table Company Profile and Development Status of Endo International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo International

    • Figure Sales and Growth Rate Analysis of Endo International

    • Figure Revenue and Market Share Analysis of Endo International

    • Table Product and Service Introduction of Endo International

    • Table Company Profile and Development Status of Amneal Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amneal Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amneal Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amneal Pharmaceuticals

    • Table Product and Service Introduction of Amneal Pharmaceuticals

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Zydus Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Zydus Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Zydus Pharmaceuticals

    • Table Product and Service Introduction of Zydus Pharmaceuticals

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Dr. Reddy's Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr. Reddy's Laboratories

    • Figure Sales and Growth Rate Analysis of Dr. Reddy's Laboratories

    • Figure Revenue and Market Share Analysis of Dr. Reddy's Laboratories

    • Table Product and Service Introduction of Dr. Reddy's Laboratories

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US